Japan’s PMDA Collecting Adverse Event Reports Directly From Patients
This article was originally published in PharmAsia News
Executive Summary
Japan's pharmaceutical regulatory agency says its pilot program for patient reports on adverse drug reactions has been running smoothly with minor changes underway.